Fmr LLC Agios Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 18,592 shares of AGIO stock, worth $771,939. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,592

Previous 17,806 4.41%

Holding current value

$771,939

Previous $521,000 18.62%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$24.53 - $35.75 $19,280 - $28,099	786 Added 4.41%	18,592 $618,000
Q1 2025 May 12, 2025	SELL	$29.3 - $35.9 $220,189 - $269,788	-7,515 Reduced 29.68%	17,806 $521,000
Q4 2024 Feb 13, 2025	SELL	$32.86 - $61.64 $659,565 - $1.24 Million	-20,072 Reduced 44.22%	25,321 $832,000
Q3 2024 Nov 13, 2024	BUY	$41.19 - $49.72 $1.38 Million - $1.67 Million	33,546 Added 283.16%	45,393 $2.02 Million
Q2 2024 Aug 13, 2024	BUY	$27.55 - $48.83 $189,461 - $335,803	6,877 Added 138.37%	11,847 $510,000
Q1 2024 May 13, 2024	BUY	$21.32 - $34.81 $7,888 - $12,879	370 Added 8.04%	4,970 $145,000
Q4 2023 Feb 13, 2024	SELL	$19.97 - $24.53 $13,859 - $17,023	-694 Reduced 13.11%	4,600 $102,000
Q3 2023 Nov 13, 2023	BUY	$24.36 - $28.18 $6,625 - $7,664	272 Added 5.42%	5,294 $131,000
Q2 2023 Aug 11, 2023	SELL	$21.38 - $29.19 $577 - $788	-27 Reduced 0.53%	5,022 $142,000
Q1 2023 May 11, 2023	SELL	$21.74 - $30.93 $35.6 Million - $50.6 Million	-1,635,265 Reduced 99.69%	5,049 $115,000
Q4 2022 Feb 13, 2023	SELL	$24.81 - $31.52 $6.61 Million - $8.39 Million	-266,240 Reduced 13.96%	1,640,314 $46.1 Million
Q3 2022 Nov 10, 2022	SELL	$19.51 - $34.14 $20.1 Million - $35.1 Million	-1,029,288 Reduced 35.06%	1,906,554 $53.9 Million
Q2 2022 Aug 12, 2022	SELL	$17.06 - $31.42 $32.1 Million - $59.2 Million	-1,882,650 Reduced 39.07%	2,935,842 $65.1 Million
Q1 2022 May 13, 2022	SELL	$26.68 - $34.81 $16.4 Million - $21.4 Million	-615,822 Reduced 11.33%	4,818,492 $140 Million
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $41.8 Million - $70.4 Million	-1,414,504 Reduced 20.65%	5,434,314 $179 Million
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $51.7 Million - $71.7 Million	-1,233,192 Reduced 15.26%	6,848,818 $316 Million
Q2 2021 Aug 13, 2021	BUY	$52.06 - $61.27 $421 Million - $495 Million	8,082,010 New	8,082,010 $445 Million

Others Institutions Holding AGIO

# of Institutions

237

Shares Held

61.8M

Call Options Held

297K

Put Options Held

235K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.28B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account